Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Bioxyne Limited ( (AU:BXN) ).
Bioxyne Limited has called a General Meeting of shareholders to be held on 19 June 2026 at the offices of Addisons in Sydney, with the session commencing at 2:00 p.m. Sydney time. The company has circulated a Notice of Meeting and Explanatory Memorandum, encouraging shareholders to submit proxy votes in advance, with all resolutions to be determined by poll and an opportunity provided for investor questions.
The meeting documentation is intended to guide shareholders on the business to be considered and the mechanics of voting, reflecting Bioxyne’s approach to formal governance and engagement with its investor base. By emphasizing proxy voting and poll-based resolution decisions, the company is aiming to ensure broader participation and a more representative outcome on matters requiring shareholder approval.
More about Bioxyne Limited
Bioxyne Limited (ASX: BXN) is an Australian-listed company headquartered in Sydney. It operates in the broader life sciences and health-related sector, with its shares held by a base of public shareholders who participate in corporate governance through general meetings and proxy voting processes.
Average Trading Volume: 4,595,267
Technical Sentiment Signal: Buy
Current Market Cap: A$173.4M
See more insights into BXN stock on TipRanks’ Stock Analysis page.